Benzeneacetic acid, 3-chloro-5-[2-[4-(1-pyrrolidinyl)-1-[5-(trifluoromethyl)thiazolo[5,4-b]pyridin-2-yl]-4-piperidinyl]ethoxy]- manufacturers
- PPARδ agonist 9
-
- $2980.00
-
2026-07-27
- CAS:928023-21-6
- Purity:
- Supply Ability: 10g
|
| | Benzeneacetic acid, 3-chloro-5-[2-[4-(1-pyrrolidinyl)-1-[5-(trifluoromethyl)thiazolo[5,4-b]pyridin-2-yl]-4-piperidinyl]ethoxy]- Basic information |
| | Benzeneacetic acid, 3-chloro-5-[2-[4-(1-pyrrolidinyl)-1-[5-(trifluoromethyl)thiazolo[5,4-b]pyridin-2-yl]-4-piperidinyl]ethoxy]- Chemical Properties |
| Boiling point | 657.6±65.0 °C(Predicted) | | density | 1.413±0.06 g/cm3(Predicted) | | pka | 4.02±0.10(Predicted) |
| | Benzeneacetic acid, 3-chloro-5-[2-[4-(1-pyrrolidinyl)-1-[5-(trifluoromethyl)thiazolo[5,4-b]pyridin-2-yl]-4-piperidinyl]ethoxy]- Usage And Synthesis |
| Uses | PPARδ agonist 9 (compound 21) is a PPARδ agonist (EC50: 3.6 nM). PPARδ agonist 9 has in vivo efficacy, reducing serum levels of MCP-1 in mice and significantly inhibiting atherosclerosis progression in the LDLr-KO model (inhibition rate: 50-60%)[1]. | | References | [1] Kato T, et al. Design, Synthesis, and Anti-Inflammatory Evaluation of a Novel PPARδ Agonist with a 4-(1-Pyrrolidinyl)piperidine Structure. J Med Chem. 2023 Aug 24;66(16):11428-11446.. DOI:10.1021/acs.jmedchem.3c00932 |
| | Benzeneacetic acid, 3-chloro-5-[2-[4-(1-pyrrolidinyl)-1-[5-(trifluoromethyl)thiazolo[5,4-b]pyridin-2-yl]-4-piperidinyl]ethoxy]- Preparation Products And Raw materials |
|